Urinary Prostaglandin E2 Excretion and the Risk of Cardiovascular and Kidney Disease.
Frank GeurtsLayal ChakerAnna C van der BurghDeirdre P Cronin-FentonRobert A FentonEwout J HoornPublished in: Journal of the American Heart Association (2024)
Urinary PGE2 and PGEM excretions are novel markers for the presence and progression of cardiovascular and kidney disease. Future studies should address whether these associations are causal and can be targeted to improve cardiovascular and kidney outcomes.